What is a Macrolide Resistance Test and why is it important for an Mgen infection?

Introduction

If you have recently been told you may have Mycoplasma genitalium (Mgen) — or you are trying to understand more about the infection and how it is managed — you may have come across the term macrolide resistance test. Understanding what this test is, and why it plays such a meaningful role in Mgen infection assessment, can help you make informed decisions about your sexual health.

Our clinic provides confidential STI testing services. We do not provide GP services or dermatology consultations, but we can advise on appropriate next steps if further medical care is needed.

Quick Answer: What is a Macrolide Resistance Test?

A macrolide resistance test is a specialist laboratory test that identifies whether a Mycoplasma genitalium (Mgen) infection carries specific genetic mutations associated with resistance to macrolide antibiotics. This matters because macrolide resistance in Mgen is increasingly common and can affect how the infection responds to treatment, making accurate testing an important step in understanding the infection.

Key points at a glance:

• Mgen is a sexually transmitted bacterial infection
• Macrolide antibiotics are commonly used in Mgen management
• Resistance mutations can affect treatment outcomes
• A macrolide resistance test identifies whether resistance-associated mutations are present
• Testing provides important information for healthcare providers managing Mgen

Symptoms alone cannot confirm an Mgen infection or whether resistance is present.

When Could Mgen Symptoms Be Linked to an STI?

Symptoms sometimes associated with Mgen — such as unusual discharge, urethral discomfort, or pelvic discomfort — can have a range of possible causes. Many people with Mgen experience mild or no symptoms at all. Because these symptoms overlap with those of other conditions, testing is the only reliable way to determine whether Mgen is present and whether a macrolide resistance test may be appropriate.

Section 1: Understanding Mycoplasma Genitalium (Mgen)

Mycoplasma genitalium is a sexually transmitted bacterial infection caused by a small bacterium that affects the genital and urinary tracts. It is transmitted through unprotected sexual contact, including vaginal and anal sex.

Mgen is considered one of the more common STIs in the UK, though it is less widely discussed than chlamydia or gonorrhoea. Many people who carry the infection are unaware of it, as symptoms can be absent or very mild. When symptoms do occur, they may include:

• Unusual discharge from the penis or vagina
• Burning or discomfort when urinating
• Pelvic pain or discomfort (more commonly in women)
• Inflammation of the urethra (urethritis)

Because these symptoms are non-specific, Mgen can only be confirmed through laboratory testing.

Section 2: What Are Macrolides and Why Do They Matter for Mgen?

Macrolides are a class of antibiotic. In the context of Mgen infection, azithromycin — a macrolide antibiotic — has historically been used as part of the treatment approach. However, Mgen has demonstrated an increasing ability to develop resistance to macrolide antibiotics.

Macrolide resistance in Mgen occurs when genetic mutations develop within the bacterium, reducing the effectiveness of macrolide-based antibiotics. This is a clinically significant concern, as it means some Mgen infections may not respond as expected to standard treatment approaches.

A macrolide resistance test is designed to detect these specific mutations at a genetic level, providing important information that can inform clinical decision-making.

Section 3: What Does a Macrolide Resistance Test Involve?

A macrolide resistance test for Mgen is a molecular laboratory test, often performed using a sample collected via:

• A urine sample
• A genital swab (vaginal, cervical, or urethral)
• A rectal swab, where appropriate

The sample is analysed using PCR (polymerase chain reaction) technology, which can detect the presence of Mgen and simultaneously identify whether mutations associated with macrolide resistance are present.

At our clinic, we provide confidential Mgen testing with resistance profiling, with results processed through accredited laboratories and delivered discreetly.

Section 4: Why is Macrolide Resistance Testing Important for Mgen?

The clinical importance of macrolide resistance testing in Mgen cannot be overstated. Here is why it matters:

Resistance is increasingly prevalent

Research indicates that macrolide resistance in Mgen is a growing concern across the UK and internationally. Without resistance testing, there is no way to determine whether a standard antibiotic approach is likely to be appropriate for a particular infection.

It informs clinical management

When a healthcare provider knows whether macrolide resistance mutations are present, they are better placed to discuss appropriate next steps. This is why many UK sexual health guidelines now recommend that Mgen testing includes macrolide resistance profiling as standard.

It helps avoid treatment delays

If macrolide resistance is not identified early, there is a risk that the infection may persist. Identifying resistance at the point of testing supports timely and appropriate onward clinical management.

Section 5: How Does Mgen Differ From Other STIs?

Unlike some other sexually transmitted infections, Mgen is not yet as widely understood or routinely tested for. It does not always cause obvious symptoms, meaning it can go undetected for some time. This is one reason why testing — including macrolide resistance assessment — is particularly important for those with potential exposure.

STIs that may produce overlapping symptoms include:

• Chlamydia — often causes urethral discharge or no symptoms
• Gonorrhoea — may produce discharge and discomfort
• Trichomoniasis — can cause irritation and discharge
• Mgen — symptoms frequently overlap with the above

Because these infections can present similarly, a full STI screen may be appropriate in certain situations, particularly following unprotected sex or a new sexual partner.

Section 6: When Might Mgen Testing Be Sensible?

Testing for Mgen — with macrolide resistance profiling — may be worth considering in circumstances such as:

• Unprotected sexual contact with a new or casual partner
• A current or recent sexual partner has been diagnosed with Mgen
• Symptoms such as unusual discharge or urethral discomfort are present
• A previous STI diagnosis has been made
• You are seeking reassurance following potential exposure

Testing decisions are personal and depend on individual circumstances, exposure history, and symptom presentation.

Section 7: How Confidential STI Testing Works

At our clinic, the testing process is straightforward and discreet:

1. Sample collection — urine samples or swabs are collected, depending on the test required
2. Laboratory analysis — samples are processed at an accredited laboratory using PCR technology
3. Results delivery — results are provided confidentially, typically within a few days
4. Onward signposting — where a positive result is returned, we can advise on appropriate next steps, including referral to a healthcare provider for clinical management

We provide testing services only and do not prescribe treatment. If a positive result is returned, we can advise on appropriate healthcare pathways.

Section 8: Frequently Asked Questions

Can Mgen cause symptoms similar to other STIs?

Yes. Mgen symptoms such as discharge or urethral discomfort can overlap with those of chlamydia, gonorrhoea, and other infections. Testing is the only way to confirm which infection, if any, is present.

Does everyone with Mgen have symptoms?

No. Many people with Mgen experience no symptoms at all, which is one reason why testing following potential exposure is important.

What is the difference between an Mgen test and a macrolide resistance test?

An Mgen test confirms whether the bacterium is present. A macrolide resistance test additionally identifies whether resistance-associated mutations are present within the detected infection.

Should I still test if symptoms have resolved?

If there has been potential exposure, testing may still be appropriate even if symptoms have settled. Some infections can persist without causing ongoing symptoms.

Is an [Mgen test](https://www.sticlinic.co.uk/mycoplasma-genitalium-test) included in a full STI screen?

This depends on the screening package chosen. It is worth checking which infections are included when selecting a testing option.

How soon can Mgen be detected after exposure?

Laboratory detection windows vary. A healthcare provider or clinic can advise on appropriate testing timing based on individual circumstances.

Section 9: When to Seek Medical Advice

Whilst many symptoms associated with Mgen or urogenital discomfort are not cause for alarm, there are situations where prompt healthcare consultation is advisable:

• Severe pelvic pain
• Fever alongside urogenital symptoms
• Symptoms that are worsening or not resolving
• Ulcers, sores, or unusual skin changes in the genital area
• Symptoms spreading or changing in character

If symptoms persist or worsen, consultation with an appropriate healthcare service is advised.

Confidential STI Testing in the UK

If you are concerned about possible Mgen exposure or would like to understand more about macrolide resistance testing, confidential STI testing appointments are available at our clinic. Testing decisions depend on symptoms, exposure history, and individual risk factors.

Visit www.sticlinic.co.uk to learn more about available testing services or to book a confidential appointment.

Medical Disclaimer: This article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Sexual health concerns should be assessed based on individual circumstances. If you are experiencing persistent, severe, or worsening symptoms, consultation with an appropriate healthcare service is advised. Our clinic provides private STI testing services only.